An accumulation of pathological data have been proved that FBXW7 is a tumor suppressor by targetting various oncogenic proteins, such as Notch, cyclin E, c-Myc, and c-Jun, for degradation [73,74]. This evidence concerns the gene MYC and neoplasm.